Breast-density notification letters may be too dense
(Reuters Health) - Post-mammogram form letters telling women about dense breasts may be more confusing than helpful if they are difficult to read and understand, researchers say.
(Reuters Health) - Post-mammogram form letters telling women about dense breasts may be more confusing than helpful if they are difficult to read and understand, researchers say.
When news emerged that Qatar may have unwittingly helped bail out a New York skyscraper owned by the family of Jared Kushner, Donald Trump's son-in-law, eyebrows were raised in Doha.
A U.S. judge on Friday threw out the state of Maryland's bid to protect the healthcare law known as Obamacare in a ruling that also sidestepped a decision on whether President Donald Trump's appointment of Matthew Whitaker as acting attorney general was lawful.
Canada's Liberal government will propose a limited expansion to the country's universal healthcare system in the spring budget to cover part of the cost of prescription drugs, two sources with direct knowledge of the matter told Reuters.
U.S. Democratic Senator Patty Murray sent a letter to Johnson & Johnson on Tuesday seeking information related to allegations in a Reuters Special Report that the healthcare company knew about the presence of asbestos in its talc-based baby powder.
CVS Health Corp's Aetna and a host of other health insurers said on Thursday they have partnered with IBM Corp to create a blockchain network aimed at cutting costs in the healthcare industry.
China will step up its fight against "irregularities" in the sale of healthcare products after a series of scandals in the industry in recent months, state media reported on Thursday, citing senior officials.
Australian Pharmaceutical Industries Ltd (API) said on Wednesday it was expected to start due diligence on its A$727 million ($518.6 million) offer for pharmacy operator Sigma Healthcare Ltd soon.
Walgreens Boots Alliance Inc will pay $269.2 million to settle two whistleblower lawsuits accusing it of civil fraud for overbilling federal healthcare programs over a decade, the U.S. Department of Justice said on Tuesday.
The U.S. Supreme Court on Tuesday refused to revive Swiss drug company Helsinn Healthcare S.A.'s patent on the lucrative anti-nausea drug Aloxi in a victory for Teva Pharmaceutical Industries, which launched a generic version of it last year.